Microgestin 1.5/30

  • Contraception

Microgestin 1.5/30 Generic Name & Formulations

General Description

Norethindrone acetate 1.5mg, ethinyl estradiol 30mcg (21 tabs).

Pharmacological Class

Progestin + estrogen.

How Supplied

Packs (Fe 1/20, Fe 1.5/30)—3, 6; Packs (1/20, 1.5/30)—6


Microgestin 1.5/30 Indications


Oral contraception.

Microgestin 1.5/30 Dosage and Administration


28-day products: 1 tab daily for 28 days; repeat. 21-day products: 1 tab daily for 21 days, then 7 tablet-free days; repeat.


Not applicable.

Microgestin 1.5/30 Contraindications


Thrombophlebitis or thromboembolic disorders. History of DVT, cerebrovascular or coronary artery disease. Known or suspected breast carcinoma, endometrial or other estrogen-dependent neoplasia. Undiagnosed abnormal genital bleeding. Cholestatic jaundice of pregnancy or jaundice with prior OC use. Hepatic adenoma or carcinoma. Pregnancy (Cat.X).

Microgestin 1.5/30 Boxed Warnings

Boxed Warning

Cigarette smoking increases risk of serious cardiovascular events.

Microgestin 1.5/30 Warnings/Precautions


Increased risk of cardiovascular events esp. in cigarette smokers >35yrs of age; not recommended. Discontinue if thrombotic event, unexplained visual changes, jaundice, or headache/migraine occurs, and at least 4 weeks before through 2 weeks after surgery associated with increased risk of thromboembolism, and during and after prolonged immobilization. Cardio- or cerebrovascular diseases. Gallbladder disease. Obesity. Diabetes. Prediabetes. Hypertriglyceridemia. Depression. Conditions aggravated by fluid retention; monitor. Evaluate significant changes in headaches, irregular uterine bleeding, amenorrhea, retinal vein thrombosis. Monitor BP. Do regular complete physical exams. May need barrier contraception with Sunday starts or postpartum use (see full labeling). Nursing mothers: not recommended.

Microgestin 1.5/30 Pharmacokinetics

See Literature

Microgestin 1.5/30 Interactions


Antagonized by hepatic enzyme inducing drugs (eg, rifampin, griseofulvin, St. John's wort), possibly others. May affect measurement of sex hormone-binding globulin levels.

Microgestin 1.5/30 Adverse Reactions

Adverse Reactions

Hypertension, nausea, vomiting, breakthrough bleeding, amenorrhea, transient delay of ovulation after discontinuation, edema, chloasma, mastodynia, headache, intolerance to contact lenses. Increased risk of gallbladder disease, thromboembolic disorders.

Microgestin 1.5/30 Clinical Trials

See Literature

Microgestin 1.5/30 Note

Not Applicable

Microgestin 1.5/30 Patient Counseling

See Literature